의료진
의료진소개
원규장
- [진료과] 내분비대사내과
- [주연구분야] 당뇨병의 치료 (췌장소도 생물학)
- [직위] 교수, 의학연구처장
- [진료과목] 당뇨병, 내분비대사 질환
진료예약
| 의사 | 진료과목 | 구분 | 월 | 화 | 수 | 목 | 금 | 토 | 예약 |
|---|---|---|---|---|---|---|---|---|---|
| 원규장 | 당뇨병, 내분비대사 질환 | 오전 | 예약가능● | 예약가능● | 예약가능● |
전화 예약 (620-4030) |
|||
| 오후 | 예약가능● | ||||||||
| * 진료과 사정으로 전화예약 053 620 4030만 예약 가능합니다. | |||||||||
경력
영남의대 졸
의학박사
Pacific Northwest Research Institute、Seattle 연수
現) 영남대의료원 의생명연구처장
영남대병원 혁신형의사과학자공동연구사업단 단장
대한당뇨병학회 이사장 (2022~2023)
前) 대한내분비학회 부회장
대한내분비학회 연구이사
대한당뇨병학회 간행이사, 학술이사
대구경북내분비당뇨학회 지회장
영남대의료원 기획조정실장
사무국장
QI 실장
영남대학교의과대학 교무부학장
영남대병원 내과과장
건강증진센터장
대한당뇨병학회 평의원
대한내분비학회 평의원
대한내과학회 평의원
미국 당뇨병학회 정회원
미국 내분비학회 정회원
의학박사
Pacific Northwest Research Institute、Seattle 연수
現) 영남대의료원 의생명연구처장
영남대병원 혁신형의사과학자공동연구사업단 단장
대한당뇨병학회 이사장 (2022~2023)
前) 대한내분비학회 부회장
대한내분비학회 연구이사
대한당뇨병학회 간행이사, 학술이사
대구경북내분비당뇨학회 지회장
영남대의료원 기획조정실장
사무국장
QI 실장
영남대학교의과대학 교무부학장
영남대병원 내과과장
건강증진센터장
대한당뇨병학회 평의원
대한내분비학회 평의원
대한내과학회 평의원
미국 당뇨병학회 정회원
미국 내분비학회 정회원
학회 및 대외활동
《발표 논문》
2023 Moon JS, Kim NH, Na JO, Cho JH, Jeong IK, Lee SH, Mok JO, Kim NH, Chung DJ, Cho J, Lee DW, Lee SW, Won KC. Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance. Diabetes b J. 2023 Jan;47(1):82-91. doi: 10.4093/dmj.2021.0356. Epub 2022 Jun 20
2022 Chung SM, Heo DG, Kim JH, Yoon JS, Lee HW, Kim JY, Moon JS, Won KC. compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study. Environ Health. 2022 Oct 26;21(1):101. doi: 10.1186/s12940-022-00915-2
2022 Karunakaran U, Elumalai S, Moon JS, Won KC. c-Abl Tyrosine Kinase Inhibition Attenuate Oxidative Stress-Induced Pancreatic β-Cell Dysfunction via Glutathione Antioxidant System. Transl Res 2022 Jun 10;S1931-5244(22)00139-6. doi: 10.1016/j.trsl.2022.06.007
2022 Park IR, Choi J, Ha EY, Chung SM, Moon JS, Shin S, Kim SG, Won KC. Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes. Clin Hemorheol Microcirc. 2022;81(4):293-303. doi: 10.3233/CH-211326.
2021 Elumalai S, Karunakaran U, Moon JS, Won KC. Pioglitazone-Induced AMPK-Glutaminase-1 Prevents High Glucose-Induced Pancreatic β-cell Dysfunction by Glutathione antioxidant system. Redox Biol. https://doi.org/10.1016/j.redox.2021.102029
2020 Elumalai S, Karunakaran U, Moon JS, Won KC. High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic β-cells: Prevention by teneligliptin. Free Radic Biol Med 2020, 618-629.
2019 Moon JS, Chung SM, Jang SH, Won KC*, Chang MC. (co-correspondence) Effects of Diabetes on Motor Recovery after Cerebral Infarct: A Diffusion Tensor Imaging Study. J Clin Endocrinol b. 2019 Apr 4. pii: jc.2018-02502. (Epub ahead of print).
2019 Karunakaran U, Elumalai S, Moon JS, Jeon JH, Kim ND, Park KG, Won KC, Leem J, Lee IK. Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5. Diabetes b J. 2019 Jan 16. [Epub ahead of print]
2019 Karunakaran U, Elumalai S, Moon JS, Won KC* (*co-corresponding). CD36 dependent redoxosomes promotes ceramide-mediated pancreatic β-cell failure via p66Shc activation. Free Radic Biol Med. 2019;134:505-515.
2019 Chung SM, Moon JS, Yoon JS, Won KC*, Lee HW. Sex-specific effects of blood cadmium on thyroid hormones and thyroid function status: Korean nationwide cross-sectional study. J Trace Elem Med Biol. 2019; 53:55-61
2018 Won KC. A Short but Long Journey with You.DIABETES & BOLISM JOURNAL. 42(1)
2018 Won KC et al. Smart Care d on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial. TELEMEDICINE AND E-HEALTH. 24(8)
2018 Won KC et.al.Low urine pH affects the development of bolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study. PLOS ONE. 13(8) e0202757 (*co-correspondence)
2017 Elumalai S, Karunakaran U, Lee IK, Moon JS, Won KC. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells. Redox Biol. 11: 126–134 (*co-correspondence)
2017 Moon JS, Karunakaran U, Elumalai S, Lee IK, Lee HW, Kim YW, Won KC. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 in pancreatic beta cells. J Diabetes Complications. 31:21-30 (Correspondance)
2016 Moon JS, Kim JH, Kim JH, Park IR, Lee JH, Kim HJ, Lee J, Kim YK, Yoon JS, Won KC*, Lee HW. Impaired RBC deformability is associated with diabetic retinopathy in patients with type 2 diabetes. Diabetes b. 42:448-452, (*co-correspondence)
2016 Yoon JS, Moon JS, Kim YW, Won KC, Lee HW. The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36. J Korean Med Sci. 2016 Apr; 31(4):547-552 (Correspondance)
2015 Karunakaran U, Moon JS, Lee HW, Won KC. CD36 initiated signaling mediates ceramide-induced TXNIP in pancreatic beta-cells. Biochim Biophys Acta. 2015 ;1852(11):2414-22 (Correspondance)
2015 Moon JS, Won KC. Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block. Diabetes b J. 2015;39(1):1-9
2014 Moon JS, Ha KS, Yoon JS, Lee HW, Lee HC, Won KC; BETA study group. The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study. Acta Diabetol. 2014;51(2):277-85
2013 Moon JS, Yoon JS, Won KC, Lee HW. The role of skeletal muscle in development of nonalcoholic Fatty liver disease. Diabetes b J. 2013;37(4):278-85
2013 Chung HH, Moon JS, Yoon JS, Lee HW, Won KC. The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes. Diabetes b J. 2013 Apr;37(2):125-31
2012 Kim YW, Moon JS, Seo YJ, Park SY, Kim JY, Yoon JS, Lee IK, Lee HW, Won KC. Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells. Biochem Biophys Res Commun. 2012 ;420(2):462-6
2023 Moon JS, Kim NH, Na JO, Cho JH, Jeong IK, Lee SH, Mok JO, Kim NH, Chung DJ, Cho J, Lee DW, Lee SW, Won KC. Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance. Diabetes b J. 2023 Jan;47(1):82-91. doi: 10.4093/dmj.2021.0356. Epub 2022 Jun 20
2022 Chung SM, Heo DG, Kim JH, Yoon JS, Lee HW, Kim JY, Moon JS, Won KC. compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study. Environ Health. 2022 Oct 26;21(1):101. doi: 10.1186/s12940-022-00915-2
2022 Karunakaran U, Elumalai S, Moon JS, Won KC. c-Abl Tyrosine Kinase Inhibition Attenuate Oxidative Stress-Induced Pancreatic β-Cell Dysfunction via Glutathione Antioxidant System. Transl Res 2022 Jun 10;S1931-5244(22)00139-6. doi: 10.1016/j.trsl.2022.06.007
2022 Park IR, Choi J, Ha EY, Chung SM, Moon JS, Shin S, Kim SG, Won KC. Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes. Clin Hemorheol Microcirc. 2022;81(4):293-303. doi: 10.3233/CH-211326.
2021 Elumalai S, Karunakaran U, Moon JS, Won KC. Pioglitazone-Induced AMPK-Glutaminase-1 Prevents High Glucose-Induced Pancreatic β-cell Dysfunction by Glutathione antioxidant system. Redox Biol. https://doi.org/10.1016/j.redox.2021.102029
2020 Elumalai S, Karunakaran U, Moon JS, Won KC. High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic β-cells: Prevention by teneligliptin. Free Radic Biol Med 2020, 618-629.
2019 Moon JS, Chung SM, Jang SH, Won KC*, Chang MC. (co-correspondence) Effects of Diabetes on Motor Recovery after Cerebral Infarct: A Diffusion Tensor Imaging Study. J Clin Endocrinol b. 2019 Apr 4. pii: jc.2018-02502. (Epub ahead of print).
2019 Karunakaran U, Elumalai S, Moon JS, Jeon JH, Kim ND, Park KG, Won KC, Leem J, Lee IK. Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5. Diabetes b J. 2019 Jan 16. [Epub ahead of print]
2019 Karunakaran U, Elumalai S, Moon JS, Won KC* (*co-corresponding). CD36 dependent redoxosomes promotes ceramide-mediated pancreatic β-cell failure via p66Shc activation. Free Radic Biol Med. 2019;134:505-515.
2019 Chung SM, Moon JS, Yoon JS, Won KC*, Lee HW. Sex-specific effects of blood cadmium on thyroid hormones and thyroid function status: Korean nationwide cross-sectional study. J Trace Elem Med Biol. 2019; 53:55-61
2018 Won KC. A Short but Long Journey with You.DIABETES & BOLISM JOURNAL. 42(1)
2018 Won KC et al. Smart Care d on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial. TELEMEDICINE AND E-HEALTH. 24(8)
2018 Won KC et.al.Low urine pH affects the development of bolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study. PLOS ONE. 13(8) e0202757 (*co-correspondence)
2017 Elumalai S, Karunakaran U, Lee IK, Moon JS, Won KC. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells. Redox Biol. 11: 126–134 (*co-correspondence)
2017 Moon JS, Karunakaran U, Elumalai S, Lee IK, Lee HW, Kim YW, Won KC. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 in pancreatic beta cells. J Diabetes Complications. 31:21-30 (Correspondance)
2016 Moon JS, Kim JH, Kim JH, Park IR, Lee JH, Kim HJ, Lee J, Kim YK, Yoon JS, Won KC*, Lee HW. Impaired RBC deformability is associated with diabetic retinopathy in patients with type 2 diabetes. Diabetes b. 42:448-452, (*co-correspondence)
2016 Yoon JS, Moon JS, Kim YW, Won KC, Lee HW. The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36. J Korean Med Sci. 2016 Apr; 31(4):547-552 (Correspondance)
2015 Karunakaran U, Moon JS, Lee HW, Won KC. CD36 initiated signaling mediates ceramide-induced TXNIP in pancreatic beta-cells. Biochim Biophys Acta. 2015 ;1852(11):2414-22 (Correspondance)
2015 Moon JS, Won KC. Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block. Diabetes b J. 2015;39(1):1-9
2014 Moon JS, Ha KS, Yoon JS, Lee HW, Lee HC, Won KC; BETA study group. The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study. Acta Diabetol. 2014;51(2):277-85
2013 Moon JS, Yoon JS, Won KC, Lee HW. The role of skeletal muscle in development of nonalcoholic Fatty liver disease. Diabetes b J. 2013;37(4):278-85
2013 Chung HH, Moon JS, Yoon JS, Lee HW, Won KC. The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes. Diabetes b J. 2013 Apr;37(2):125-31
2012 Kim YW, Moon JS, Seo YJ, Park SY, Kim JY, Yoon JS, Lee IK, Lee HW, Won KC. Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells. Biochem Biophys Res Commun. 2012 ;420(2):462-6
